VR Logo

CareDx Inc. (CDNA) download report


Healthcare | Diagnostics Services

CareDx Inc. (CDNA) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide.

IPO Date: 17-Jul-2014

Pres, CEO & Director: Dr. Reginald Seeto

Chief Marketing Officer & Franchise Head of Kidney Transplant: Ms. Sasha King M.B.A.

Listing: NASDAQ: CDNA

Country: United States

Headquarters: South San Francisco, CA

Website: https://www.caredx.com

Key Facts

Market cap: $1,175.65 Mln

Revenue (TTM): $308.41 Mln

Earnings (TTM): $-49.62 Mln

Cash: $319.22 Mln

Total Debt: $20.43 Mln

Insider's Holding: 1.85%

Liquidity: Low

52 Week range: $19.36 - 92.55

Shares outstanding: 53,221,100

10 Years Aggregate:

  • CFO: $-38.89 Mln
  • EBITDA: $-183.78 Mln
  • Net Profit: $-234.57 Mln

Stock Performance

Time Period CareDx (CDNA) S&P BSE Sensex S&P Small-Cap 600
YTD-51.64-9.18-19.12
1 month-15.95-4.78-8.39
3 months-40.54-9.66-14.02
1 Year-75.970.81-17.54
3 Years-15.1410.335.95
5 Years81.7211.345.78
10 Years--11.749.79
As on 01-Jul-2022
Year CareDx (CDNA) S&P Small-Cap 600 S&P BSE Sensex
2021-37.2325.2721.99
2020235.889.5715.75
2019-14.2020.8614.38
2018240.22-9.705.87
2017171.8511.7327.91
2016-57.8124.741.95
2015-11.72-3.36-5.03